Literature DB >> 6761087

Candida albicans vaginitis: the problem is diagnosis, the enigma is treatment.

T B Lebherz, L C Ford.   

Abstract

At the UCLA Vulvovaginitis Clinic, 63 patients were diagnosed as having symptomatic Candida albicans vaginal infections. In a random select manner 3-day treatment with 200-mg clotrimazole suppositories was compared with 7-day treatment using 100-mg clotrimazole suppositories. 7- and 35-day follow-up of all patients entered revealed no statistical difference between the two groups, suggesting that short-term treatment is most efficacious and can be expected to work better since patient compliance is primarily a function of duration of treatment. In 50 cases of C. albicans patients treated with miconazole or clotrimazole in a random manner, the recurrence rate was 8 or 16. All patients in the study received perianal cultures for C. albicans before treatment and 7 and 35 days after treatment. 5 of the 8 patients with recurrence had perianal positive cultures at the 7- and 35-day check suggesting this as a source of recurrence. It is suggested that patients with persistently high perianal cultures after treatment be given an oral fungicide or fungistat to lower chronic recurrent C. albicans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6761087     DOI: 10.1159/000238157

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  2 in total

1.  Protocol for a randomised controlled trial of treatment of asymptomatic candidiasis for the prevention of preterm birth [ACTRN12610000607077].

Authors:  Christine L Roberts; Jonathan M Morris; Kristen R Rickard; Warwick B Giles; Judy M Simpson; George Kotsiou; Jennifer R Bowen
Journal:  BMC Pregnancy Childbirth       Date:  2011-03-11       Impact factor: 3.007

Review 2.  Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis.

Authors:  Christine L Roberts; Charles S Algert; Kristen L Rickard; Jonathan M Morris
Journal:  Syst Rev       Date:  2015-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.